The e-SELECT Registry a MULTICENTER POST-MARKET SURVEILLANCE "A multicenter prospective observational registry of the CYPHER SELECT Sirolimus- eluting Coronary Stent and of all future generation of commercially approved Cordis Sirolimus- eluting Stents."
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms E-SELECT
- Sponsors Cordis Corporation
- 25 Aug 2011 Official Title amended, Company added as trial sponsor as reported by Clinical Trials Registry - India.
- 03 Feb 2010 New source identified and integrated (Clinical Trials Registry - India, CTRI2008-091-000170).
- 17 Dec 2009 Planned number of patients changed from 30000 to 15000 as reported by ClinicalTrials.gov.